Logo

NCI’s Cancer Research Center Will Use BioFortis' Labmatrix Software

Jul 13, 2006

NEW YORK (GenomeWeb News) - BioFortis today said that the National Cancer Institute selected its Labmatrix software for use within the Center for Cancer Research.

 
CCR evaluated the software within the Neuro Oncology Branch.
 
Labmatrix is a web-based, enterprise translational research information-management software platform. It integrates clinical data with genomic, proteomic, and laboratory experimental data, and maintains annotated tissue banks.
 
The National Institutes of Health collaborated with BioFortis in developing Labmatrix.
 
CCR is composed of multiple labs, branches, and core facilities supporting both clinical and basic sciences, with a focus on translational cancer research.

Filed under

Informatics
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.